2023 Early Hearing Detection & Intervention Conference

March 5-7, 2023 • Cincinnati, OH

<< BACK TO AGENDA

10/26/2019  |   2:15 PM - 3:15 PM   |  Effect of the Starkey Hearing Foundation Phase 4 Intervention on Speech, Language and Audition on Pupils Living with Hearing Impairment in Kochi; a Quasi Controlled Trial   |  Ventana Ballroom C

Effect of the Starkey Hearing Foundation Phase 4 Intervention on Speech, Language and Audition on Pupils Living with Hearing Impairment in Kochi; a Quasi Controlled Trial

Background: The Starkey Hearing Foundation (SHF) observed that most parents and teachers for the hearing impaired in low to middle-income countries do not use speech in the classrooms or homes (total communication strategy) and that could prevent the pupils from developing speech and audition or make them lose it, if they ever developed it. Objective: To assess the impact of the SHF’s intervention on the speech, language and audition of pupils living with hearing impairment Design: A quasi-controlled trial of children living with hearing impairment in India Method: Ninety-five pupils from two schools were participants. Of these, 50 in one of the schools were categorized as intervention group, and 45 from the second school were the control group, and both groups had similar participants. Pupils tested were aged 4-8 years. Children with cochlear implants were excluded from the study. Interventions: Children in the intervention group received SHF hearing aids, their teachers and at least one parent each received training to inculcate the culture of listening and speaking to the children both in class and at home while the control group received only hearing aids. The intervention took 6 months. Main Outcomes Measures: Speech, language and audition improvement in the participants Results: Experimental group had 89.3% improvement in sound identification as compared to 22.9% in the control group (p 0.001). Change in speech inventory showed a significant difference (p 0.02) of 70.1% compared to 40.2% when experimental and control groups where compared. SECs combined receptive assessment showed 52% increment in experimental group compared to 4.5% in the control, the expressive component showed 41.7% as opposed to 11.3% with both statistically significant at (p 0.001) and (p 0.0002) respectively. Conclusion: Overall, the result indicates the SHF Phase 4 program can improve audition, speech and language of children living with hearing impairment

  • Culturally adaptive technique to integrate total communication in schools for the hearing impaired
  • A model to involve family members in the care of hearing impaired kids
  • Advocacy for pre-school screening policy in LMICs

Presentation:
This presentation has not yet been uploaded.

Handouts:
Handout is not Available

Transcripts:
CART transcripts are NOT YET available, but will be posted shortly after the conference


Presenters/Authors

Luqman Lawal (), Starkey Hearing Foundation/ University of Minnesota SPH, Luqman_Lawal@starkeyfoundation.org;
Luqman Lawal MD, MPH is a Public health Physician who serves as the Director of Global health and Research at the Starkey Hearing Foundation.


ASHA DISCLOSURE:

Financial -

Nonfinancial -

Chalese Buttars (), Starkey Hearing Foundation, chalese_buttars@starkeyfoundation.org;
Chalese serves as the Mission Audiologist for the Starkey Hearing Foundation


ASHA DISCLOSURE:

Financial -

Nonfinancial -

Prem Nair (), Department of Audiology and Speech Pathology, Amrita University, gprems@aims.amrita.edu;
Professor at the Department of Audiology and Speech Pathology, Amrita University


ASHA DISCLOSURE:

Financial -

Nonfinancial -

Jeffery Larsen (), Utah State University , jeffery.larsen@usu.edu;
Jeff Larsen is a faculty member of the Department of Communicative Disorders and Deaf Education at Utah State University. He works in the adult audiology clinic, teaches courses, and conducts research. His primary interests are speech perception, classroom acoustics, humanitarian audiology, and vestibular outcomes in the case of mild traumatic brain injury.


ASHA DISCLOSURE:

Financial -

Nonfinancial -